Kadekar Darshana, Kale Vaijayanti, Limaye Lalita
Stem Cell Laboratory, National Centre for Cell Science, University of Pune Campus, Ganeshkhind, Pune, 411007, Maharashtra, India.
Stem Cell Res Ther. 2015 Oct 19;6:201. doi: 10.1186/s13287-015-0194-y.
Ex vivo expansion of umbilical cord blood (UCB) is attempted to increase cell numbers to overcome the limitation of cell dose. Presently, suspension cultures or feeder mediated co-cultures are performed for expansion of hematopoietic stem cells (HSCs). Mesenchymal stem cells (MSCs) have proved to be efficient feeders for the maintenance of HSCs. Here, we have established MSCs-HSCs co-culture system with MSCs isolated from less invasive and ethically acceptable sources like umbilical cord tissue (C-MSCs) and placenta (P-MSCs). MSCs derived from these tissues are often compared with bone marrow derived MSCs (BM-MSCs) which are considered as a gold standard. However, so far none of the studies have directly compared C-MSCs with P-MSCs as feeders for ex vivo expansion of HSCs. Thus, we for the first time performed a systematic comparison of hematopoietic supportive capability of C and P-MSCs using paired samples.
UCB-derived CD34(+) cells were isolated and co-cultured on irradiated C and P-MSCs for 10 days. C-MSCs and P-MSCs were isolated from the same donor. The cultures comprised of serum-free medium supplemented with 25 ng/ml each of SCF, TPO, Flt-3 L and IL-6. After 10 days cells were collected and analyzed for phenotype and functionality.
C-MSCs and P-MSCs were found to be morphologically and phenotypically similar but exhibited differential ability to support ex vivo hematopoiesis. Cells expanded on P-MSCs showed higher percentage of primitive cells (CD34(+)CD38(-)), CFU (Colony forming unit) content and LTC-IC (Long term culture initiating cells) ability. CD34(+) cells expanded on P-MSCs also exhibited better in vitro adhesion to fibronectin and migration towards SDF-1α and enhanced NOD/SCID repopulation ability, as compared to those grown on C-MSCs. P-MSCs were found to be closer to BM-MSCs in their ability to expand HSCs. P-MSCs supported expansion of functionally superior HSCs by virtue of reduction in apoptosis of primitive HSCs, higher Wnt and Notch activity, HGF secretion and cell-cell contact. On the other hand, C-MSCs facilitated expansion of progenitors (CD34(+)CD38(+)) and differentiated (CD34(-)CD38(+)) cells by secretion of IL1-α, β, MCP-2, 3 and MIP-3α.
P-MSCs were found to be better feeders for ex vivo maintenance of primitive HSCs with higher engraftment potential than the cells expanded with C-MSCs as feeders.
尝试对脐带血(UCB)进行体外扩增以增加细胞数量,从而克服细胞剂量的限制。目前,造血干细胞(HSC)的扩增采用悬浮培养或饲养层介导的共培养方法。间充质干细胞(MSC)已被证明是维持HSC的有效饲养层。在此,我们建立了一种MSC-HSC共培养系统,所用的MSC分离自侵袭性较小且符合伦理规范的来源,如脐带组织(C-MSC)和胎盘(P-MSC)。源自这些组织的MSC常与被视为金标准的骨髓来源的MSC(BM-MSC)进行比较。然而,到目前为止,尚无研究直接比较C-MSC和P-MSC作为HSC体外扩增饲养层的效果。因此,我们首次使用配对样本对C-MSC和P-MSC的造血支持能力进行了系统比较。
分离脐血来源的CD34(+)细胞,并与经辐照的C-MSC和P-MSC共培养10天。C-MSC和P-MSC取自同一供体。培养体系为无血清培养基,添加25 ng/ml的干细胞因子(SCF)、血小板生成素(TPO)、Flt-3配体(Flt-3 L)和白细胞介素-6(IL-6)。10天后收集细胞,分析其表型和功能。
发现C-MSC和P-MSC在形态和表型上相似,但在支持体外造血方面表现出不同的能力。在P-MSC上扩增的细胞显示出更高比例的原始细胞(CD34(+)CD38(-))、集落形成单位(CFU)含量和长期培养起始细胞(LTC-IC)能力。与在C-MSC上生长的细胞相比,在P-MSC上扩增的CD34(+)细胞在体外对纤连蛋白的黏附性更好,对基质细胞衍生因子-1α(SDF-1α)的趋化性更强,并且非肥胖型糖尿病/重症联合免疫缺陷(NOD/SCID)小鼠的再增殖能力增强。发现P-MSC在扩增HSC的能力上更接近BM-MSC。P-MSC通过减少原始HSC的凋亡、提高Wnt和Notch活性、分泌肝细胞生长因子(HGF)以及细胞间接触来支持功能更优的HSC的扩增。另一方面,C-MSC通过分泌白细胞介素-1α、β、单核细胞趋化蛋白-2、3和巨噬细胞炎性蛋白-3α来促进祖细胞(CD34(+)CD38(+))和分化细胞(CD34(-)CD38(+))的扩增。
发现P-MSC是体外维持具有更高植入潜力的原始HSC的更好饲养层,优于以C-MSC作为饲养层扩增的细胞。